Stay updated on Adjuvant IDE196 in Localized Ocular Melanoma Clinical Trial

Sign up to get notified when there's something new on the Adjuvant IDE196 in Localized Ocular Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant IDE196 in Localized Ocular Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record for the Phase 2 darovasertib trial in localized ocular melanoma is displayed, with details on participation criteria, study design and outcomes, and participating locations. The record also indicates the study is active but no longer recruiting.
    Difference
    56%
    Check dated 2026-11-11T17:42:57.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of study details.
    Difference
    0.2%
    Check dated 2026-10-28T15:51:09.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T20:45:10.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.2 instead of v3.7.1. The page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-14T20:37:30.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-07T20:57:45.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, with the standard header/footer visible; this indicates the study record is currently inaccessible or restricted.
    Difference
    18%
    Check dated 2026-09-23T22:01:20.000Z thumbnail image

Stay in the know with updates to Adjuvant IDE196 in Localized Ocular Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant IDE196 in Localized Ocular Melanoma Clinical Trial page.